APO RESEARCH · REPORT
Precision Medicine
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Product & engineering
Understand the product.
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
Selected research
Industry Research
Precision Medicine Industry Research Report 2026
Market perspective
According to the National Institutes of Health (NIH), precision medicine is "an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person." This approach will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. It is in contrast to a "one-size-fits-all" approach, in which disease treatment and prevention strategies are developed for the average person, with less consideration for the differences between individuals.
Although the term "precision medicine" is relatively new, the concept has been a part of healthcare for many years. For example, a person who needs a blood transfusion is not given blood from a randomly selected donor; instead, the donor’s blood type is matched to the recipient to reduce the risk of complications. Although examples can be found in several areas of medicine, the role of precision medicine in day-to-day healthcare is relatively limited. Researchers hope that this approach will expand to many areas of health in coming years.
The classification of precision medicine includes diagnostics and therapies, and the proportion of diagnostics is about 67%.
Read the full market overview
Precision Medicine is used for oncology, neurosciences, immunology, respiratory and other field. The most proportion of precision medicine is for oncology, and the market share is about 30%.
Market competition is intense. Johnson & Johnson, Roche, Labcorp, Abbott Laboratories and Novartis are the leaders of the industry, with about 56% market shares.
Report Scope
This report quantifies the global Precision Medicine market in terms of revenue (US$ million) and, where applicable, service volume (), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Precision Medicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Precision Medicine Market by Company
Johnson & Johnson
Roche
Labcorp
Abbott Laboratories
Novartis
Illumina
GE Healthcare
Intel Corporation
Biomrieux Sa
Cepheid
IBM
Qiagen
Thermo Fisher Scientific
Randox Laboratories
Almac Group
Healthcore
Precision Medicine Segment by Type
Diagnostics
Therapies
Precision Medicine Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
Precision Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Precision Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Precision Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Precision Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Precision Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Diagnostics
- Therapies
Applications
- Oncology
- Neurosciences
- Immunology
- Respiratory
- Others
Companies covered
- Johnson & Johnson
- Roche
- Labcorp
- Abbott Laboratories
- Novartis
- Illumina
- GE Healthcare
- Intel Corporation
- Biomrieux Sa
- Cepheid
- IBM
- Qiagen
- Thermo Fisher Scientific
- Randox Laboratories
- Almac Group
- Healthcore
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Precision Medicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Diagnostics
- 2.2.3 Therapies
- 2.3 Precision Medicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Oncology
- 2.3.3 Neurosciences
- 2.3.4 Immunology
- 2.3.5 Respiratory
- 2.3.6 Others
- 2.4 Assumptions and Limitations
3 Precision Medicine Breakdown Data by Type
- 3.1 Global Precision Medicine Historic Market Size by Type (2021-2026)
- 3.2 Global Precision Medicine Forecasted Market Size by Type (2027-2032)
4 Precision Medicine Breakdown Data by Application
- 4.1 Global Precision Medicine Historic Market Size by Application (2021-2026)
- 4.2 Global Precision Medicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Precision Medicine Market Perspective (2021-2032)
- 5.2 Global Precision Medicine Growth Trends by Region
- 5.2.1 Global Precision Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Precision Medicine Historic Market Size by Region (2021-2026)
- 5.2.3 Precision Medicine Forecasted Market Size by Region (2027-2032)
- 5.3 Precision Medicine Market Dynamics
- 5.3.1 Precision Medicine Industry Trends
- 5.3.2 Precision Medicine Market Drivers
- 5.3.3 Precision Medicine Market Challenges
- 5.3.4 Precision Medicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Precision Medicine Players by Revenue
- 6.1.1 Global Top Precision Medicine Players by Revenue (2021-2026)
- 6.1.2 Global Precision Medicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Precision Medicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Precision Medicine Head Office and Area Served
- 6.4 Global Precision Medicine Players, Product Type & Application
- 6.5 Global Precision Medicine Manufacturers Established Date
- 6.6 Global Precision Medicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Precision Medicine Market Size (2021-2032)
- 7.2 North America Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Precision Medicine Market Size by Country (2021-2026)
- 7.4 North America Precision Medicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Precision Medicine Market Size (2021-2032)
- 8.2 Europe Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Precision Medicine Market Size by Country (2021-2026)
- 8.4 Europe Precision Medicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Precision Medicine Market Size (2021-2032)
- 9.2 Asia-Pacific Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Precision Medicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Precision Medicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Precision Medicine Market Size (2021-2032)
- 10.2 South America Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Precision Medicine Market Size by Country (2021-2026)
- 10.4 South America Precision Medicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Precision Medicine Market Size (2021-2032)
- 11.2 Middle East & Africa Precision Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Precision Medicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Precision Medicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Johnson & Johnson
- 12.1.1 Johnson & Johnson Company Information
- 12.1.2 Johnson & Johnson Business Overview
- 12.1.3 Johnson & Johnson Revenue in Precision Medicine Business (2021-2026)
- 12.1.4 Johnson & Johnson Precision Medicine Product Portfolio
- 12.1.5 Johnson & Johnson Recent Developments
- 12.2 Roche
- 12.2.1 Roche Company Information
- 12.2.2 Roche Business Overview
- 12.2.3 Roche Revenue in Precision Medicine Business (2021-2026)
- 12.2.4 Roche Precision Medicine Product Portfolio
- 12.2.5 Roche Recent Developments
- 12.3 Labcorp
- 12.3.1 Labcorp Company Information
- 12.3.2 Labcorp Business Overview
- 12.3.3 Labcorp Revenue in Precision Medicine Business (2021-2026)
- 12.3.4 Labcorp Precision Medicine Product Portfolio
- 12.3.5 Labcorp Recent Developments
- 12.4 Abbott Laboratories
- 12.4.1 Abbott Laboratories Company Information
- 12.4.2 Abbott Laboratories Business Overview
- 12.4.3 Abbott Laboratories Revenue in Precision Medicine Business (2021-2026)
- 12.4.4 Abbott Laboratories Precision Medicine Product Portfolio
- 12.4.5 Abbott Laboratories Recent Developments
- 12.5 Novartis
- 12.5.1 Novartis Company Information
- 12.5.2 Novartis Business Overview
- 12.5.3 Novartis Revenue in Precision Medicine Business (2021-2026)
- 12.5.4 Novartis Precision Medicine Product Portfolio
- 12.5.5 Novartis Recent Developments
- 12.6 Illumina
- 12.6.1 Illumina Company Information
- 12.6.2 Illumina Business Overview
- 12.6.3 Illumina Revenue in Precision Medicine Business (2021-2026)
- 12.6.4 Illumina Precision Medicine Product Portfolio
- 12.6.5 Illumina Recent Developments
- 12.7 GE Healthcare
- 12.7.1 GE Healthcare Company Information
- 12.7.2 GE Healthcare Business Overview
- 12.7.3 GE Healthcare Revenue in Precision Medicine Business (2021-2026)
- 12.7.4 GE Healthcare Precision Medicine Product Portfolio
- 12.7.5 GE Healthcare Recent Developments
- 12.8 Intel Corporation
- 12.8.1 Intel Corporation Company Information
- 12.8.2 Intel Corporation Business Overview
- 12.8.3 Intel Corporation Revenue in Precision Medicine Business (2021-2026)
- 12.8.4 Intel Corporation Precision Medicine Product Portfolio
- 12.8.5 Intel Corporation Recent Developments
- 12.9 Biomrieux Sa
- 12.9.1 Biomrieux Sa Company Information
- 12.9.2 Biomrieux Sa Business Overview
- 12.9.3 Biomrieux Sa Revenue in Precision Medicine Business (2021-2026)
- 12.9.4 Biomrieux Sa Precision Medicine Product Portfolio
- 12.9.5 Biomrieux Sa Recent Developments
- 12.10 Cepheid
- 12.10.1 Cepheid Company Information
- 12.10.2 Cepheid Business Overview
- 12.10.3 Cepheid Revenue in Precision Medicine Business (2021-2026)
- 12.10.4 Cepheid Precision Medicine Product Portfolio
- 12.10.5 Cepheid Recent Developments
- 12.11 IBM
- 12.11.1 IBM Company Information
- 12.11.2 IBM Business Overview
- 12.11.3 IBM Revenue in Precision Medicine Business (2021-2026)
- 12.11.4 IBM Precision Medicine Product Portfolio
- 12.11.5 IBM Recent Developments
- 12.12 Qiagen
- 12.12.1 Qiagen Company Information
- 12.12.2 Qiagen Business Overview
- 12.12.3 Qiagen Revenue in Precision Medicine Business (2021-2026)
- 12.12.4 Qiagen Precision Medicine Product Portfolio
- 12.12.5 Qiagen Recent Developments
- 12.13 Thermo Fisher Scientific
- 12.13.1 Thermo Fisher Scientific Company Information
- 12.13.2 Thermo Fisher Scientific Business Overview
- 12.13.3 Thermo Fisher Scientific Revenue in Precision Medicine Business (2021-2026)
- 12.13.4 Thermo Fisher Scientific Precision Medicine Product Portfolio
- 12.13.5 Thermo Fisher Scientific Recent Developments
- 12.14 Randox Laboratories
- 12.14.1 Randox Laboratories Company Information
- 12.14.2 Randox Laboratories Business Overview
- 12.14.3 Randox Laboratories Revenue in Precision Medicine Business (2021-2026)
- 12.14.4 Randox Laboratories Precision Medicine Product Portfolio
- 12.14.5 Randox Laboratories Recent Developments
- 12.15 Almac Group
- 12.15.1 Almac Group Company Information
- 12.15.2 Almac Group Business Overview
- 12.15.3 Almac Group Revenue in Precision Medicine Business (2021-2026)
- 12.15.4 Almac Group Precision Medicine Product Portfolio
- 12.15.5 Almac Group Recent Developments
- 12.16 Healthcore
- 12.16.1 Healthcore Company Information
- 12.16.2 Healthcore Business Overview
- 12.16.3 Healthcore Revenue in Precision Medicine Business (2021-2026)
- 12.16.4 Healthcore Precision Medicine Product Portfolio
- 12.16.5 Healthcore Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst